No earnings within 2 weeks of this transaction.
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Jan 12, 2026 |
| Expiration Date | Apr 19, 2032 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 12, 2026 |
| Shares Purchased | 200,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 5,244,834 |
| Derivative | Derivative |
| Accession Number | 0001140361-26-001239 |
| Document | View SEC Filing |